Diagnosis and Management of von Willebrand Disease in the United Kingdom

被引：9

作者：

Keeney, Steve ^{[1
]}

Collins, Peter ^{[2
]}

Cumming, Anthony ^{[1
]}

Goodeve, Anne ^{[3
]}

Pasi, John ^{[4
]}

机构：

[1] Manchester Royal Infirm, Mol Diagnost Ctr Haematol, Manchester M13 9WL, Lancs, England

[2] Cardiff Univ, Dept Haematol, Sch Med, Univ Wales Hosp, Cardiff, S Glam, Wales

[3] Sheffield Childrens NHS Fdn Trust, Sheffield Diagnost Genet Serv, Sheffield, S Yorkshire, England

[4] Barts & London Queen Marys Sch Med & Dent, Haemophilia Ctr, London, England

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2011年 / 37卷 / 05期

关键词：

von Willebrand disease; inherited bleeding disorders; service specification; UK Haemophilia Centre Doctors' Organization; National Haemophilia Database; CENTER-DOCTORS-ORGANIZATION; BLEEDING DISORDERS; HEMOPHILIA; GUIDELINE; PREVALENCE;

D O I：

10.1055/s-0031-1281033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The UK treatment strategy for von Willebrand disease (VWD) is based on consensus guidelines produced by the United Kingdom Haemophilia Centre Doctors' Organization (UKHCDO) relating to the diagnosis and management of VWD. Selection of therapeutic products suitable for treatment of this complex inherited bleeding disorder is based on the observed response. Desmopressin (DDAVP), an analog of vasopressin, is the recommended treatment in individuals who respond to this drug on trial infusion. DDAVP clearly has no effect in type 3 VWD but may have variable clinical effect in individuals with other subtypes or may be contraindicated in some cases. In patients where DDAVP treatment is unsuitable, replacement factor concentrate containing von Willebrand factor (VWF) is the recommended alternative. Relevant concentrates are available for all patients in the United Kingdom, and treatment is administered by a network of 67 hemophilia treatment centers that also provide specialist care for individuals diagnosed with VWD. Patients diagnosed with the condition are registered on a national inherited bleeding disorder database administered by the UKHCDO on behalf of the Department of Health to aid in service planning and commissioning. Genetic testing is employed in the United Kingdom in certain situations, which is also performed in accordance with current UKHCDO guidelines.

引用

页码：488 / 494

页数：7

共 13 条

[1]

HILL FGH, 1982, CLIN OBSTET GYNAECOL, V9, P75

[2]

Kadir RA, 1998, HAEMOPHILIA, V4, P836

[3] Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders - A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline - Approved by the British Committee for Standards in Haematology [J].

Keeling, D. ;

Tait, C. ;

Makris, M. .

HAEMOPHILIA, 2008, 14 (04) :671-684

[4] The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network [J].

Keeney, S. ;

Bowen, D. ;

Cumming, A. ;

Enayat, S. ;

Goodeve, A. ;

Hill, M. .

HAEMOPHILIA, 2008, 14 (05) :1099-1111

[5] The diagnosis of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors' Organization [J].

Laffan, M ;

Brown, SA ;

Collins, PW ;

Cumming, AM ;

Hill, FGH ;

Keeling, D ;

Peake, IR ;

Pasi, KJ .

HAEMOPHILIA, 2004, 10 (03) :199-217

[6]

*OFF NAT STAT, OFF NAT STAT UK POP

[7] Management of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors' Organization [J].

Pasi, KJ ;

Collins, PW ;

Keeling, DM ;

Brown, SA ;

Cumming, AM ;

Dolan, GC ;

Hay, CRM ;

Hill, FGH ;

Laffan, M ;

Peake, IR .

HAEMOPHILIA, 2004, 10 (03) :218-231

[8] Type 1 von Willebrand disease [J].

Peake, I. ;

Goodeve, A. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 :7-11

[9]

RODEGHIERO F, 1987, BLOOD, V69, P454

[10] Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor [J].

Sadler, J. E. ;

Budde, U. ;

Eikenboom, J. C. J. ;

Favaloro, E. J. ;

Hill, F. G. H. ;

Holmberg, L. ;

Ingerslev, J. ;

Lee, C. A. ;

Lillicrap, D. ;

Mannucci, M. ;

Mazurier, C. ;

Meyer, D. ;

Nichols, W. L. ;

Nishino, M. ;

Peake, I. R. ;

Rodeghiero, F. ;

Schneppenheim, R. ;

Ruggeri, Z. M. ;

Srivastava, A. ;

Montgomery, R. R. ;

Federici, A. B. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) :2103-2114

← 1 2 →